BONK, INC. — fact timeline

Mitchell Rudy was appointed as President at BONK, INC..

“On April 27, 2026 the board of directors (the “ Board ”) of Bonk, Inc. (the “ Company ”) appointed Mitchell Rudy to serve as President of the Company, effective immediately.”

Chris Melton was appointed as Chairman of the Board at BONK, INC..

“the board of directors (the “ Board ”) of Bonk, Inc. (the “ Company ”) appointed Chris Melton as the Company’s Chairman of the Board effective immediately.”

BONK, INC.: Amended Third Amended and Restated Certificate of Incorporation to effect a 1-for-35 reverse stock split (effective 2025-12-11).

“On December 9, 2025, Bonk, Inc., a Delaware corporation (the “Company”), filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Third Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a reverse stock split of the Company’s common stock, $0.001 par value per share (“Common Stock”), at a rate of 1-for-35 (the “Reverse Stock Split”), effective as of 12:01 a.m. Eastern Time on December 11, 2025.”

BONK, INC.: Increased authorized shares of common stock from 250,000,000 to 1,000,000,000 (effective 2025-11-04).

“On November 4, 2025, the Company filed the Amendment with the Secretary of State of the State of Delaware, which became effective when filed on November 4, 2025.”

BONK, INC. received a nasdaq deficiency notice notice regarding other (rules 5635(b), 5640, 5250(e)).

“) that the previously disclosed private placements that the Company entered into on August 8, 2025 and August 29, 2025 (the “Transactions”) together and individually failed to comply with the following Nasdaq Listing Rules (the “Rules”): (i) notification requirements under Listing Rules 5250(b)(1), 5250(e)(2)(B) and 5250(e)(2)(D); (ii) Shareholder Approval requirements under Listing Rules 5635(a) and 5635(b); and (iii) Voting Rights requirements under Listing Rule 5640. The Letter further stated that based on the Company’s corrective actions to amend the Transactions and subsequent disclosures”

BONK, INC.: 修改Series C优先股指定证书，增加关于董事会选举权的‘逐步下调条款’ (effective 2025-10-10).

“On October 10, 2025, the Company, upon approval of the Company’s Board of Directors and the sole holder of the Company’s Series C Convertible Preferred Stock, par value $0.001 per share (the “ Series C Preferred Stock ”), filed an Amendment to the Amended and Restated Certificate of Designation of Series C Preferred Stock with the Secretary of State of the State of Delaware (the “ Series C Certificate of Designation Amendment ”). The Series C Certificate of Designation Amendment adds a “step-down provision” in respect of the rights granted to the holders of Series C Preferred Stock to elect members of the Board.”

BONK, INC.: 公司名称变更为Bonk, Inc.，交易代码变更为BNKK (effective 2025-10-10).

“On September 16, 2025, the Board approved the change in the name of the Company to “Bonk, Inc.” (the “Name Change”) and the change in the trading symbol of the Company to “BNKK” on the Nasdaq Capital Market (the “Symbol Change”) to align with its major transformation into a BONK strategy company. On October 8, 2025, to effectuate the Name Change, the Company filed a Certificate of Amendment of the Certificate of Incorporation of the Company, as amended and restated (the “Charter Amendment”), with the Secretary of State of the State of Delaware. The Name Change and the Symbol Change took effect on the Nasdaq Capital Market on October 10, 2025.”

BONK, INC.: Amended and Restated Certificate of Designation of Series C Preferred Stock to change the conversion price from $0.5582 to $1.081, effective August 15, 2025 (effective 2025-08-15).

“On August 15, 2025, Safety Shot, Inc. (the “ Company ”), upon approval of the Company’s Board of Directors and the sole holder of the Company’s Series C Convertible Preferred Stock, par value $0.001 per share (the “ Series C Preferred ”), filed an Amended and Restated Certificate of Designation of Series C Preferred Stock with the Secretary of State of the State of Delaware (the “ Amended and Restated Series C Certificate of Designation ”), pursuant to which the conversion price for the Company’s Series C Preferred was amended and restated from $.5582 to equal $1.081, which dollar figure represents the average Official Nasdaq Closing Price for the five trading days preceding August 9, 2025, with no other changes being made to the designations, rights or preferences of the Series C Preferred.”

BONK, INC.: Certificate of Designation of Series C Preferred Stock filed to establish rights, preferences, and designations (effective 2025-08-11).

“Pursuant to the Securities Purchase Agreement and the Revenue Sharing Agreement, on August 11, 2025, the Company filed a Certificate of Designation of Series C Preferred Stock with the Secretary of State of the State of Delaware (the “ Series C Certificate of Designation ”).”

BONK, INC. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“isting Rule 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq’s Notice has no immediate effect on the listing or trading of our”

BONK, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 2, 2025, Safety Shot, Inc., (the “Company”) received a notice from The Nasdaq Stock Exchange (“Nasdaq”) that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecutive days, and that we are therefore not in compliance with the minimum bid price requirement for continued inclusion on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). Nasdaq’s Notice has no immediate effect on the listing or trading of our common stock on the Nasdaq Capital Market. On July 9, 2025, the Company received a notification (the “Ex”

BONK, INC.: On July 2, 2025, the Company filed a Certificate of Designation with the Delaware Secretary of State designating 10,000 shares as Series B Convertible Preferred Stock, setting forth rights, preferences, and limitations (effective 2025-07-02).

“On July 2, 2025, the Company filed a Certificate of Designation (the “ Certificate of Designation ”) with the Delaware Secretary of State designating, 10,000 shares as Series B Convertible Preferred Stock (the “ Series B Preferred Stock ”), each with a stated value of $750 per share (the “ Stated Value ”). The Certificate of Designation sets forth the rights, preferences and limitations of the shares of Series B Preferred Stock.”

BONK, INC. completed an acquisition involving Yerbaé Brands Corp. for 19,881,948 Safety Shot Shares (closed 2025-06-27).

“greement on January 7, 2025 (the “ Arrangement Agreement ”) with Yerbaé Brands Corp. (“ Yerbaé ”), pursuant to which the Company agreed, among other things, to acquire all of the issued and outstanding common shares of Yerbaé”

BONK, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“January 2, 2025, Safety Shot, Inc., (the “Company”) received a notice from The Nasdaq Stock Exchange (“Nasdaq”) that the closing bid price for our common stock had been below $1.00 per share for the previous 30 consecuti”

BONK, INC. entered into Registration Rights Agreement with the Investors valued at Company agreed to file registration statements covering the Shares (effective 2024-04-04).

“On April 4, 2024, the Company also entered into a Registration Rights Agreement with the Investors (the “Registration Rights Agreement” and together with the SPA the “Agreements”), requiring the Company to register the Shares issued under the SPA.”

David Sandler was appointed as Chief Operating Officer at BONK, INC..

“On March 25, 2024, the board of directors (the “Board”) of the Company appointed David Sandler as the Chief Operating Officer of the Company.”

David Long was appointed as Director at BONK, INC..

“On March 8, 2024, the Board the Company appointed David Long as a member of the Board.”

Jordan Schur was appointed as Director at BONK, INC..

“On March 13, 2024, the board of directors (the “Board”) of Safety Shot, Inc. (the “Company”) appointed Jordan Schur as a member to the Board, and as the President of the Company.”

Jordan Schur was appointed as President at BONK, INC..

“On March 13, 2024, the board of directors (the “Board”) of Safety Shot, Inc. (the “Company”) appointed Jordan Schur as a member to the Board, and as the President of the Company.”

Brian S. John resigned as Director at BONK, INC..

“On February 28, 2024, Mr. John resigned from the Board.”

Brian S. John resigned as Chief Executive Officer at BONK, INC..

“On February 28, 2024, Brian S. John resigned from his position as the Chief Executive Officer of the Company, effective immediately.”

Markita L. Russell resigned as Chief Financial Officer at BONK, INC..

“On February 28, 2024, Markita L. Russell resigned from her position as the Chief Financial Officer of the Company, effective February 29, 2024.”

Danielle De Rosa was appointed as Chief Financial Officer at BONK, INC..

“On February 27, 2024, the board of directors (the “Board”) appointed Danielle De Rosa as the Chief Financial Officer of the Company, effective March 1, 2024.”

BONK, INC. entered into License and Purchase Agreement with Elite Health Partners Inc. valued at 4,000,000 shares of Licensee Common Stock; option to purchase Legacy Assets for $1.00 upon IPO compl (effective 2024-02-21).

“On February 21, 2024, Safety Shot Inc. (the “ Company ”) entered into a License and Purchase Agreement (the “ Purchase Agreement ”), with Elite Health Partners Inc., a Delaware corporation (“ Licensee ”), pursuant to which the Company granted to Licensee a license to use assets related to the development and sale of various over-the-counter health and wellness products owned by the Company (the “ Legacy Assets ”) and the option to purchase the Legacy Assets upon fulfillment by Licensee of certain conditions set forth in the Purchase Agreement.”

BONK, INC. shareholders approved Election of seven directors to serve until the 2023 Annual Meeting of Stockholders or until their earlier resignation or removal. at the 2023-12-05 meeting.

“1. The Company’s stockholders elected seven directors, each to serve until his/her successor is duly elected and qualified at the 2023 Annual Meeting of Stockholders or until his/her earlier resignation or removal. The number of shares that (a) voted for the election of each director, (b) voted against the election of each director, and (c) abstained or withheld authority to vote for each director is summarized in the table below: Director Nominee Votes For Votes Against Votes Abstained or Withheld Brian John 13,348,298 253,339 116,744 Dr. Glynn Wilson 13,301,989 306,379 110,013 Nancy Torres Kaufman 13,536,204 160,964 21,213 Christopher Melton 12,286,329 1,313,203 118,849 Jarrett Boon 13,308,649 296,925 112,807 Dr. Hector Alila 4,674,398 8,933,208 110,775 John Gulyas 13,534,124 155,516 28,741”

BONK, INC. shareholders approved Ratification of the 2023 Equity Incentive Plan, including the reservation of 7,000,000 shares of common stock..

“Proxies were solicited on behalf of the Board of Directors of the Company and a vote by ballot was taken for and against the ratification of the 2023 Equity Incentive Plan, including the reservation of 7,000,000 shares of common stock. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes For Votes Against Votes Withheld 11,614,569 1,929,120 174,692”

BONK, INC. shareholders approved Ratification of the appointment of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-12-31 meeting.

“Proxies were solicited on behalf of the Board of Directors of the Company and a vote by ballot was taken for and against the ratification of the appointment of M&K CPAS, PLLC (“M&K”) as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. The number of shares that voted for, against, and withheld from voting for this proposal is summarized in the table below: Votes For Votes Against Votes Withheld 22,836,925 106,737 35, 519”

BONK, INC. shareholders approved Election of seven directors to serve until the 2023 Annual Meeting of Stockholders or until their successors are elected and qualified..

“The Company’s stockholders elected seven directors, each to serve until his/her successor is duly elected and qualified at the 2023 Annual Meeting of Stockholders or until his/her earlier resignation or removal. The number of shares that (a) voted for the election of each director, (b) voted against the election of each director, and (c) withheld authority to vote for each director is summarized in the table below: Director Nominee Votes For Votes Against Votes Withheld Brian S. John 13,348,298 253,339 116,744 Dr. Glynn Wilson 13,301,989 306,379 110,013 Dr. Skender Fani 13,536,204 160,964 21,213 Nancy Torres Kaufman 12,286,329 1,313,203 118,849 Christopher Melton 13,308,649 296,925 112,807 Jarrett Boon 4,674,398 8,933,208 110,775 Dr. Hector Alila 13,534,124 155,516 28,741”

Richard Pascucci was appointed as member of the board of directors at BONK, INC..

“the Board appointed Richard Pascucci as a member of the Board to fill in the vacancy created by the removal of Mr. Alila.”

Dr. Hector Alila was removed as member of the board of directors at BONK, INC..

“the shareholders voted against the re-election of Dr. Hector Alila. As a result, Dr. Alila was removed from his position as a member of the board of directors (the “Board”), effective December 6, 2023.”